A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
The purpose of this study is to find out whether AZD1390 combined with stereotactic body radiation therapy/SBRT is a safe treatment for people with metastatic solid tumor cancer
Solid Tumor|Metastatic Solid Tumor|Solid Carcinoma|Solid Tumor, Adult|Metastatic Tumor|Metastatic Cancer
DRUG: AZD1390|RADIATION: Stereotactic Body Radiotherapy
Assess participants for toxicities related to study treatment, The primary objective is to assess the safety and tolerability of concurrent AZD1390 with SBRT for patients with solid tumor metastases with solid tumor metastases. Participant toxicities will be assessed using the CTCAE v5.0, 1 year
The purpose of this study is to find out whether AZD1390 combined with stereotactic body radiation therapy/SBRT is a safe treatment for people with metastatic solid tumor cancer